Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unsupervised Suboxone versus wait-list control for heroin addiction
ACTRN12609000138280Phase 4Completed
- Sponsor
- Hunter New England Local Health District
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Suboxone in heroin addiction (2 arms), sponsored by Hunter New England Local Health District. Primary endpoint: Reduction in heroin use. Started Apr 2009; status: completed.
02
Drugs
Suboxone
03
Conditions
heroin addiction
Beyond the preview
Go deeper on ACTRN12609000138280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000138280.